The Korean Journal of Blood Transfusion : eISSN 2383-6881 / pISSN 1226-9336
Table. 4.

819 cases* distributed of confirmed (C), strengthened (S), and weakened/lost (W/L) classified by the four reaction stages for single identified antibodies

Antibodies identified Cases LISS/Coombs NaCl/Enzyme 4℃ RT
C (%) C (%) S (%) W/L (%) C (%) S (%) C (%)
D 53 43 (81.1) 10 (18.9) 35 (66.0)
E 281 246 (87.5) 35 (12.5) 157 (55.9)
C 66 58 (87.9) 8 (2.1) 34 (51.5)
c 90 31 (34.4) 59 (65.6) 23 (25.6)
e 54 30 (55.6) 24 (44.4) 28 (51.9)
Le(a) 48 14 (29.2) 31 (64.6) 9 (18.8) 3 (6.3)
Le(b) 32 7 (21.9) 21 (65.6) 5 (15.6) 4 (12.5)
Jk(a) 13 12 (92.3) 1 (7.7) 5 (38.5)
Jk(b) 7 6 (85.7) 1 (14.3)
K 2 2 (100.0) 0 1 (50.0)
M 90 39 (43.3) 0 84 (93.3) 51 (56.7) 14 (15.6 )
S 6 4 (66.7) 1 (16.7) 1 (16.7) 1 (16.7) 1 (16.7)
P1 62 0 (0.0) 19 (30.6) 39 (62.9) 2 (3.2) 4 (6.5)
Kp(a) 1 0 (0.0) 1 (100.0)
Fy(b) 12 8 (66.7) 0 12 (100.0) 4 (33.3)
f(ce) 1 1 (100.0) 0 1 (100.0)
Xg(a) 1 0 (0.0) 0 1 (100.0) 1 (100.0)
Total 819 501 (61.2) 211 (25.8) 297 (36.3) 99 (12.1) 98 (12.0) 17 (2.1) 9 (1.1)

*In the cases involving mixed antibodies with unidentified antibodies, the other remaining identified antibodies are classified by single antibodies after excluding unidentified antibodies.

Abbreviation: RT, room temperature.

Korean J Blood Transfus 2023;34:198-210 https://doi.org/10.17945/kjbt.2023.34.3.198
© 2023 Korean J Blood Transfus